logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
E

Eriko Tokunaga

breast oncology

49H指数
364论文数
1.3W被引数
收录论文 140
发表时间
logo
Summary of Research: HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast CancerHER2CLIMB-05研究总结：曲拉妥尼（Tucatinib）对比安慰剂联合曲妥珠单抗和帕妥珠单抗用于HER2阳性转移性乳腺癌的一线维持治疗的三期研究
errTargeted Oncology
IF4
err2026-09-19
err0
errOAAI
errVeronique Dieras; Giuseppe Curigliano; Miguel Martin; Florence Lerebours; Junji Tsurutani; Marie-France Savard; Katarzyna J. Jerzak; Xichun Hu; Ciara C. O’Sullivan; Eriko Tokunaga; Alicia Okines; Chiun-Sheng Huang; William Jacot; Joohyuk Sohn; Eduardo Cronemberger Silva; Volkmar Mueller; Shan Yang; Giovanna Granata; Qi Shen; Erika Hamilton
err分享
err收藏
E7389-LF as a first-line chemotherapy for patients with metastatic/advanced HER2-negative breast cancer: results from the phase 1 dose-expansion part of study 114E7389-LF作为HER2阴性转移性/晚期乳腺癌患者的一线化疗方案：研究114第1期剂量扩展部分的结果
errBreast Cancer Research
IF5.6
err2026-09-17
err0
errOAAI
errHiroshi Ishiguro; Yasuo Miyoshi; Hiroyuki Yasojima; Junichiro Watanabe; Toshimi Takano; Akihiko Shimomura; Eriko Tokunaga; Toru Mukohara; Yasuto Naoi; Daiko Matsuoka; Shiori Okumura; Yohei Otake; Takuya Suzuki; Takao Takase; Taro Semba; Ziming Zhao; Kan Yonemori
err分享
err收藏
Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer在JBCRG-M06/EMERALD研究中评估厄洛替尼联合双重HER2阻断在HER2阳性局部晚期或转移性乳腺癌中的生活质量评估
errBreast Cancer
IF2.9
err2026-06-10
err0
PREAI
errTsuguo Iwatani; Norikazu Masuda; Shigehira Saji; Takuhiro Yamaguchi; Yasuyuki Kojima; Masahiro Kitada; Hiroshi Tada; Tsutomu Iwasa; Kei Koizumi; Hideo Shigematsu; Yasuaki Sagara; Toshitaka Okuno; Yoshie Hasegawa; Eriko Tokunaga; Tadahiko Shien; Uhi Toh; Hiroki Hasegawa; Shun Osaka; Satoshi Morita; Toshinari Yamashita
err分享
err收藏
Erratum to ‘Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis’勘误表 '从1级间质性肺病/肺炎恢复后曲妥珠单抗deruxtecan再治疗的汇总分析'
errAnnals of Oncology
IF65.4
err2026-01-08
err0
errOAAI
errH.S. Rugo; E. Tokunaga; H. Iwata; V. Petry; E.F. Smit; Y. Goto; D.-W. Kim; K. Shitara; J.F. Gruden; S. Modi; J. Cortés; I. Krop; P.A. Jänne; Y. Cheng; C. Taitt; F.-C. Cheng; C.A. Powell
err分享
err收藏
CDK4/6 inhibitors for premenopausal women with hormone receptor-positive/HER2-negative breast cancer; insight from Young-PEARLCDK4/6抑制剂用于激素受体阳性/HER2阴性乳腺癌的绝经前女性；来自Young-PEARL的见解
errTranslational Breast Cancer Research
IF1.4
err2026-01-01
err0
PREAI
errTokunaga, Eriko
err分享
err收藏
Optimizing Antiemetic Support in Anthracycline-Based Chemotherapy for Early Breast Cancer: Protocol for a Prospective Observational Study of Four-Drug Antiemetic Therapy Including Fosnetupitant and Olanzapine优化早期乳腺癌蒽环类化疗中的止吐支持：包含福司瑞他匹坦和奥氮平的四药止吐疗法前瞻性观察研究方案
errJMIR Research Protocols
IF1.5
err2026-01-01
err0
PREAI
errHiguchi, Ayako; Koi, Yumiko; Eto, Tomoaki; Maeda, Yuka; Tajiri, Wakako; Kawasaki, Junji; Akiyoshi, Sayuri; Ijichi, Hideki; Nakamura, Yoshiaki; Koga, Chinami; Shimokawa, Mototsugu; Shimizu, Hiroaki; Matsumoto, Toshihiro; Tokunaga, Eriko
err分享
err收藏
Transient increase in skeletal-related events after discontinuation of high-dose denosumab in cancer patients癌症患者停用高剂量denosumab后骨骼相关事件的一过性增加
errJournal of Bone Oncology
IF3.5
err2025-10-10
err0
errOAAI
errNokitaka Setsu; Nobuhiko Yokoyama; Taito Esaki; Masafumi Yamaguchi; Eriko Tokunaga; Takahito Negishi
err分享
err收藏
Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial曲妥珠单抗德鲁替康在HER2低表达转移性乳腺癌中的应用：DESTINY-Breast04随机三期试验的长期生存分析
errNature Medicine
IF50
err2025-10-08
err0
errOAAI
errShanu Modi; William Jacot; Hiroji Iwata; Yeon Hee Park; Maria Vidal Losada; Wei Li; Junji Tsurutani; Naoto T. Ueno; Khalil Zaman; Aleix Prat; Konstantinos Papazisis; Hope S. Rugo; Toshinari Yamashita; Nadia Harbeck; Seock-Ah Im; Michelino De Laurentiis; Jean-Yves Pierga; Xiaojia Wang; Andrea Gombos; Eriko Tokunaga; Cecilia Orbegoso Aguilar; Lotus Yung; Feng Xiao; Yingkai Cheng; David Cameron
err分享
err收藏
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-10-01
err4
PREAI
errCortes, Javier; Punie, Kevin; Barrios, Carlos; Hurvitz, Sara A.; Schneeweiss, Andreas; Sohn, Joohyuk; Tokunaga, Eriko; Brufsky, Adam; Park, Yeon Hee; Xu, Binghe; Hegg, Roberto; Oliveira, Mafalda; Fabi, Alessandra; Vaksman, Natalya; Valdez, Theresa; Zhang, Xinrui; Lai, Catherine; Tolaney, Sara M.
err分享
err收藏
Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis曲妥珠单抗德鲁替康再次治疗后1级间质性肺疾病/肺炎的恢复：合并分析
errAnnals of Oncology
IF65.4
err2025-08-05
err0
errOAAI
errH.S. Rugo; E. Tokunaga; H. Iwata; V. Petry; E.F. Smit; Y. Goto; D.-W. Kim; K. Shitara; J.F. Gruden; S. Modi; J. Cortés; I. Krop; P.A. Jänne; Y. Cheng; C. Taitt; F.-C. Cheng; C.A. Powell
err分享
err收藏
A retrospective multi-center cohort study investigating safety of sentinel lymph node biopsy for axillary staging in clinical T3-4c breast cancer一项回顾性多中心队列研究，探讨临床T3-4c期乳腺癌腋窝分期中哨兵淋巴结活检的安全性。
errBreast Cancer
IF2.9
err2025-08-01
err0
errOAAI
errSayaka Kuba; Yasuaki Sagara; Hiroshi Yano; Shigeto Maeda; Takehiko Sakai; Yasuyuki Kojima; Masaya Hattori; Sota Asaga; Eriko Tokunaga; Tadahiko Shien; Hiroko Bando; Keisei Anan; Nobutaka Iwakuma; Shigeki Minami; Miki Yamaguchi; Michiko Harao; Masahiro Oikawa; Takafumi Sangai; Makoto Ishitobi; Takahiro Nakayama; Tetsu Hayashida; Manami Tada; Kentaro Tamaki; Goro Kutomi; Mai Tomiguchi; Narumi Harada-Shoji; Kaname Kurashita; Kaori Terata; Kosho Yamanouchi; Makoto Kubo; Chika Yumura; Yoko Takahashi; Shigeru Imoto; Shinji Ohno; Naoki Hayashi
err分享
err收藏
The impact of breast surgery and systemic therapy on the survival of patients with de novo stage IV breast cancer
errBREAST CANCER
IF2.9
err2025-02-02
err1
errOAAI
errTokunaga, Eriko; Koi, Yumiko; Tajiri, Wakako; Koga, Chinami; Ijichi, Hideki; Akiyoshi, Sayuri; Kawasaki, Junji; Nakamura, Yoshiaki; Taguchi, Kenichi; Okamoto, Masahiro
err分享
err收藏
Impact of tumor histology on the number of positive axillary lymph nodes in sentinel lymph node-positive breast cancer肿瘤组织学对哨兵淋巴结阳性乳腺癌中阳性腋窝淋巴结数量的影响
errBREAST
IF7.9
err2025-02-01
err0
errOAAI
errKoi, Y.; Tajiri, W.; Kawasaki, J.; Akiyoshi, S.; Ijichi, H.; Nakamura, Y.; Koga, C.; Taguchi, K.; Tokunaga, E.
err分享
err收藏
Capivasertib and fulvestrant for patients with HR-positive/HER2-negative advanced breast cancer: analysis of the subgroup of patients from Japan in the phase 3 CAPItello-291 trial
errBREAST CANCER
IF2.9
err2024-10-08
err0
errOAAI
errTokunaga, Eriko; Iwata, Hiroji; Itoh, Mitsuya; Taira, Tetsuhiko; Toyama, Tatsuya; Mizuno, Toshiro; Osaki, Akihiko; Yanagita, Yasuhiro; Nakamura, Seigo; Nakamura, Rikiya; Sambe, Tomoko; Ozaki, Toshiaki; Schiavon, Gaia; Howell, Sacha J.; Toi, Masakazu
err分享
err收藏
A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancerCAPItello-291研究的简明语言摘要: 激素受体阳性的晚期乳腺癌中的Capivasertib
errFUTURE ONCOLOGY
IF2.6
err2024-09-16
err2
errOAAI
errTurner, Nicholas C.; Oliveira, Mafalda; Howell, Sacha J.; Dalenc, Florence; Cortes, Javier; Gomez, Henry L.; Hu, Xichun; Jhaveri, Komal; Krivorotko, Petr; Loibl, Sibylle; Murillo, Serafin Morales; Park, Yeon Hee; Sohn, Joo-Hyuk; Toi, Masakazu; Tokunaga, Eriko; Yousef, Samih; Zhukova, Lyudmila; de Bruin, Elza; Grinsted, Lynda; Schiavon, Gaia; Foxley, Andrew; Rugo, Hope S.
err分享
err收藏
Sentinel lymph node biopsy in clinical T3-4c breast cancer: A retrospective multicenter cohort study临床T3-4c期乳腺癌的哨兵淋巴结活检：一项回顾性多中心队列研究
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errSagara, Y.; Kuba, S.; Maeda, S.; Yano, H.; Sakai, T.; Kojima, Y.; Hattori, M.; Asaga, S.; Tokunaga, E.; Shien, T.; Bando, H.; Anan, K.; Iwakuma, N.; Yamaguchi, M.; Harao, M.; Oikawa, M.; Sangai, T.; Ishitobi, M.; Nakayama, T.; Hayashi, N.
err分享
err收藏
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer
errNPJ BREAST CANCER
IF7.6
err2024-08-22
err0
errOAAI
errNoguchi, Emi; Yamanaka, Takashi; Mukai, Hirofumi; Yamamoto, Naohito; Chung, Chi-Feng; Lu, Yen-Shen; Chang, Dwan-Ying; Sohn, Joohyuk; Kim, Gun Min; Lee, Kyung-Hun; Lee, Soo-Chin; Iwasa, Tsutomu; Iwata, Hiroji; Watanabe, Kenichi; Jung, Kyung Hae; Tanabe, Yuko; Kang, Seok Yun; Yasojima, Hiroyuki; Aogi, Kenjiro; Tokunaga, Eriko; Sim, Sung Hoon; Yap, Yoon Sim; Matsumoto, Koji; Tseng, Ling-Ming; Umeyama, Yoshiko; Sudo, Kazuki; Kojima, Yuki; Hata, Tomomi; Kuchiba, Aya; Shibata, Taro; Nakamura, Kenichi; Fujiwara, Yasuhiro; Tamura, Kenji; Yonemori, Kan
err分享
err收藏
Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study在先前接受过治疗的HER2-low不可切除/转移性乳腺癌的亚洲患者中，曲妥珠单抗deruxtecan与医生选择的治疗: DESTINY-Breast04研究的亚组分析
errBREAST CANCER
IF2.9
err2024-06-17
err2
errOAAI
errYamashita, Toshinari; Sohn, Joo Hyuk; Tokunaga, Eriko; Niikura, Naoki; Park, Yeon Hee; Lee, Keun Seok; Chae, Yee Soo; Xu, Binghe; Wang, Xiaojia; Im, Seock-Ah; Li, Wei; Lu, Yen-Shen; Aguilar, Cecilia Orbegoso; Nishijima, Soichiro; Nishiyama, Yuji; Sugihara, Masahiro; Modi, Shanu; Tsurutani, Junji
err分享
err收藏
Long-term outcomes of neoadjuvant trastuzumab emtansine plus pertuzumab (T-DM1+P) and docetaxel plus carboplatin plus trastuzumab plus pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks)
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2024-05-20
err2
errOAAI
errTakano, Toshimi; Masuda, Norikazu; Ito, Mitsuya; Inoue, Kenichi; Tanabe, Yuko; Kawaguchi, Kousuke; Yasojima, Hiroyuki; Bando, Hiroko; Nakamura, Rikiya; Yamanaka, Takashi; Ishida, Kazushige; Aruga, Tomoyuki; Yanagita, Yasuhiro; Tokunaga, Eriko; Aogi, Kenjiro; Ohno, Shinji; Kasai, Hiroi; Kataoka, Tatsuki R.; Morita, Satoshi; Toi, Masakazu
err分享
err收藏
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment (vol 31, pg 340, 2024)
errBREAST CANCER
IF2.9
err2024-05-12
err1
errOAAI
errYamamoto, Yutaka; Yamauchi, Chikako; Toyama, Tatsuya; Nagai, Shigenori; Sakai, Takehiko; Kutomi, Goro; Yoshimura, Michio; Kawai, Masaaki; Ohtani, Shoichiro; Kubota, Kazunori; Nakashima, Kazutaka; Honma, Naoko; Yoshida, Masayuki; Tokunaga, Eriko; Taira, Naruto; Iwata, Hiroji; Saji, Shigehira
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
F
Fabrice André
H 指数: 148 · 论文数: 1.8K
J
José Baselga
H 指数: 143 · 论文数: 1.4K
H
Hope S. Rugo
H 指数: 137 · 论文数: 1.6K
S
Sibylle Loibl
H 指数: 131 · 论文数: 1.5K
N
Nadia Harbeck
H 指数: 131 · 论文数: 2.1K
查看更多